A study to learn about how safe BAY 3389934 is, its suitable dose, and how it affects the participants with sepsis and coagulopathy

Status

Suspended

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-515635-30-00

Acronym

22265

Enrollment

Registered

2025-02-04

Start date

2025-03-10

Completion date

Unknown

Last updated

2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coagulopathy, Sepsis

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium, France, Germany, Netherlands

None listed

Source: EU CTIS · Data processed: Feb 4, 2026